Page 75 - SPONDYLOARTHRITIS IN COLOMBIA -

was increased in women and in men (1.5 and 1.4 respectively) and consistent across different age groups, except in the stratum of 55-64 years in which the risk in women was lower. Detailed data on the prevalence of AHT compared to the general-population are shown in table-2.
Table 2. Observed prevalence of AHT in the ASAS-COMOSPA study (Latin America*) compared with the expected prevalence in general population and prevalence of Global ASAS-COMOSPA for reference.
Observed
LA* ASAS-COMOSPA
Expected General population
Prevalence (%)
SRR ** Global ASAS-COMOSPA (CI 95%)
n (%)
Gender Men
Age n ≤24 0
25-34 4
35-44 2 45-54 6
55-64 4
≥65 7 Total 23
(%) 0
12.5
NA3 2.65 -
Women
25-34 1 35-44 2 45-54 5 55-64 1 ≥65 1 Total 10
8.3 0.9 15.3 3.8 41.6 17.0 11.1 34.3 25.0 NA 19.6 12.1
9.2 4.0 2.4 0.3
- 1.5 (0.8-2.8)
1.5 (1.0-2.1)
17 7.4
61 16.8 132 36.8 104 45.6 102 68.6 416 29.8
1308 33.1
Total (men/women) 33 21.4 12.5
8.7 7.8 28.5 14.6
57.1 30.9
70.0 NA 22.3 12.9
1.1 1.9
1.8
- 1.4 (0.9-2.2)
3.6 3.4
49 8.47
152 24.4 247 43.3
240 61.1
201 84.1 892 34.4
≤2400NA -00
n=number with a diagnosis of arterial hypertension in each gender and age group
Prevalence (%); LA*, Latin America (Data confined to patients from Colombia and México); **SRR, standardized risk ratio (ratio calculated for the age of 25-64 years); NA, not available
Hypertension defined as a history of hypertension or antihypertensive therapy use or blood pressure ≥140/90 mm Hg at the study visit.
The distribution of TB prevalence and risk is presented in table-3. Overall, the observed prevalence of TB infection in LA patients with SpA in the three countries was 3.3% (95%CI 1.8 to 5.7), which was much higher than expected from the general population (0.32%) in these three LA countries and also higher than the prevalence data of the global ASAS-COMOSPA-study (2.5%) (95%CI 2.0 to 3.0).
73